St. Louis, MO, United States of America

Derek Platt

This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek Platt. Retrieved from https://idiyas.com/inventor/derek-platt-iq0do4p9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Derek Platt: Innovator in Zika Virus Research

Introduction

Derek Platt is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of virology, particularly in the development of therapeutic solutions for Zika virus infections. His work is crucial in addressing public health challenges posed by this virus.

Latest Patents

Derek Platt holds a patent for "Antibodies to Zika virus and methods of use thereof." This patent relates to antibodies that are specific to the Zika virus and outlines methods for detecting Zika virus infection in subjects. Additionally, it discusses therapeutic antibodies that are useful in reducing viral load, showcasing his innovative approach to combating viral infections.

Career Highlights

Derek Platt is affiliated with Washington University, where he conducts research and develops new methodologies in the field of infectious diseases. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

Derek collaborates with esteemed colleagues, including Michael S. Diamond and Daved Henry Fremont. These partnerships enhance the research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Derek Platt's contributions to Zika virus research through his innovative patents and collaborations highlight his role as a key figure in the scientific community. His work continues to pave the way for advancements in therapeutic solutions for viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…